Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03936153. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT05143112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL
ClinicalTrials.gov study NCT05806099. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
ClinicalTrials.gov study NCT00640796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT02685670. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07078500. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
ClinicalTrials.gov study NCT00630721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma
ClinicalTrials.gov study NCT04250324. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease
ClinicalTrials.gov study NCT06792799. IPD Sharing: NO. Countries: 1. Publications: 0.
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
ClinicalTrials.gov study NCT03265158. IPD Sharing: NO. Countries: 1. Publications: 0.
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04423549. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
ClinicalTrials.gov study NCT02991638. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lympho
ClinicalTrials.gov study NCT07001540. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.
ClinicalTrials.gov study NCT05428670. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
ClinicalTrials.gov study NCT01144754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06696833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06822868. IPD Sharing: NO. Countries: 1. Publications: 0.
Epidemiologic Study of Persistent Polyclonal B-cell Lymphocytosis (PPBL)
ClinicalTrials.gov study NCT03296046. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies
ClinicalTrials.gov study NCT05705570. IPD Sharing: NO. Countries: 1. Publications: 0.
Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT00937183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.